StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
29
This year
1
Publishing Date
2024 - 02 - 13
1
2023 - 10 - 11
1
2023 - 10 - 09
1
2023 - 10 - 02
1
2023 - 07 - 17
1
2023 - 06 - 23
1
2023 - 06 - 14
1
2023 - 06 - 09
1
2023 - 04 - 04
1
2023 - 03 - 21
1
2022 - 10 - 12
1
2022 - 09 - 28
1
2022 - 08 - 15
1
2022 - 08 - 05
1
2022 - 05 - 16
1
2022 - 05 - 09
1
2022 - 04 - 26
1
2022 - 03 - 03
1
2022 - 02 - 25
1
2022 - 02 - 01
1
2022 - 01 - 27
1
2022 - 01 - 26
1
2021 - 11 - 23
1
2021 - 10 - 22
1
2021 - 10 - 15
1
2021 - 10 - 11
1
2021 - 07 - 28
1
2021 - 07 - 26
1
2021 - 04 - 08
1
Sector
Health technology
26
Manufacturing
3
N/a
1
Tags
Acquisition
63
Agreement
41
America
66
Application
43
Approval
53
Awards
38
Business
46
Cancer
52
Ces
44
China
87
Cloud
39
Collaboration
62
Companies
39
Conference
86
Corporation
39
Covid
44
Education
37
Energy
65
Europe
128
Events
41
Financial
246
Financial results
98
Food
37
Global
126
Group
115
Growing
60
Growth
450
Health
50
International
47
Management
65
Market
933
Meeting
42
Mobile
39
Money
55
N/a
4165
Nasdaq
41
Offering
90
Partnership
56
Pharma
57
Pharmaceutical
66
Platform
37
Positive
38
Program
50
Reach
100
Report
281
Research
363
Results
462
Services
83
Set
52
Smart
37
Software
40
Solutions
60
System
49
Technology
139
Test
39
Therapeutics
66
Treatment
75
Trial
59
Update
56
Year
98
Entities
Abbott laboratories
1
Abbvie inc.
1
Acadia pharmaceuticals inc.
1
Addex therapeutics ltd
1
Alnylam pharmaceuticals, inc.
1
Astellas pharma inc
1
Astrazeneca plc
1
Biogen inc.
2
Bristol-myers squibb company
1
Clover health investments corp - class a
1
Crispr therapeutics ag
1
Denali therapeutics inc.
1
Gilead sciences, inc.
1
Global blood therapeutics, inc.
2
Grifols sa
1
I-mab
1
Johnson & johnson
1
Koninklijke philips n.v.
1
Koninklijke philips nv
1
Medtronic plc
1
Mirum pharmaceuticals, inc.
1
Morphosys ag
1
Nektar therapeutics
1
Novartis ag
1
Nrx pharmaceuticals inc
1
Pfizer, inc.
1
Predictmedix inc.
1
Regeneron pharmaceuticals, inc.
2
Relief therapeutics holding sa
1
Sangamo therapeutics, inc.
1
Sanofi
3
Teva pharmaceutical industries ltd
2
Thermo fisher scientific inc
1
Vertex pharmaceuticals incorporated
2
Viatris inc.
1
Symbols
ABBV
1
ABT
1
ACAD
1
ADXN
1
ALNY
1
ALPMF
1
ALPMY
1
AZN
1
BIIB
2
BMY
1
CLOV
1
CRSP
1
DNLI
1
GBT
2
GIFLF
1
GIKLY
1
GILD
1
IMAB
1
JNJ
1
MDT
1
MIRM
1
MOR
1
MPSYF
1
NKTR
1
NRXP
1
NVS
1
NVSEF
1
PFE
1
PHG
1
PMEDF
1
REGN
2
RLFTF
1
RLFTY
1
RYLPF
1
SGMO
1
SNY
3
SNYNF
3
TEVJF
2
TMO
1
VRTX
2
VTRS
1
Exchanges
Nasdaq
24
Nyse
7
Crawled Date
2024 - 02 - 13
1
2023 - 10 - 11
1
2023 - 10 - 09
1
2023 - 10 - 02
1
2023 - 07 - 17
1
2023 - 06 - 23
1
2023 - 06 - 14
1
2023 - 06 - 09
1
2023 - 04 - 04
1
2023 - 03 - 21
1
2022 - 10 - 12
1
2022 - 09 - 28
1
2022 - 08 - 15
1
2022 - 08 - 05
1
2022 - 05 - 16
1
2022 - 05 - 09
1
2022 - 04 - 26
1
2022 - 03 - 03
1
2022 - 02 - 25
1
2022 - 02 - 01
1
2022 - 01 - 27
1
2022 - 01 - 26
1
2021 - 11 - 23
1
2021 - 10 - 22
1
2021 - 10 - 15
1
2021 - 10 - 11
1
2021 - 07 - 28
1
2021 - 07 - 26
1
2021 - 04 - 08
1
Crawled Time
00:00
64
00:20
7
01:00
34
02:00
15
03:00
14
04:00
8
04:20
3
05:00
19
06:00
22
07:00
29
08:00
36
08:20
3
09:00
29
10:00
33
10:13
2
10:41
2
11:00
164
11:03
2
12:00
410
12:01
6
12:03
11
12:04
2
12:15
39
12:20
87
12:25
3
12:30
66
13:00
276
13:01
6
13:03
7
13:04
3
13:05
4
13:15
24
13:20
59
13:30
60
13:47
2
14:00
193
14:01
6
14:02
2
14:08
2
14:15
20
14:20
25
14:27
3
14:30
40
15:00
127
15:01
4
15:15
9
15:20
9
15:30
25
16:00
73
16:20
19
17:00
81
18:00
61
19:00
58
20:00
72
20:20
6
21:00
111
21:03
2
22:00
78
22:15
2
23:00
57
Source
spacfeed.com
1
www.biospace.com
17
www.globenewswire.com
3
www.predictmedix.com
1
www.prnewswire.com
7
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Disease
crawled time :
09:00
save search
European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
Published:
2024-02-13
(Crawled : 09:00)
- biospace.com/
VRTX
|
$393.1
-0.27%
-0.27%
880K
|
Health Technology
|
-5.82%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
first
disease
cell
treatment
Bristol Myers Squibb Presents New Zeposia (ozanimod) Data on Long-Term Disease Progression and Cognition in Patients with Relapsing Forms of Multiple Sclerosis
Published:
2023-10-11
(Crawled : 09:00)
- biospace.com/
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-14.42%
|
O:
0.16%
H:
0.73%
C:
0.3%
disease
sclerosis
Reshaping Cystic Fibrosis Disease Landscape Report | Epidemiology Study, Drug Insights, Unmet Needs Analysis, KOL Perspectives Product Launch Services, and Regulatory Consulting |Disease Landscape Insights
Published:
2023-10-09
(Crawled : 09:00)
- prnewswire.com
ALPMY
|
News
|
$9.34
-1.11%
690K
|
Manufacturing
|
-31.47%
|
O:
-0.04%
H:
0.77%
C:
0.7%
drug
disease
report
fibrosis
Navigating the Anaemia Disease Landscape: Market Insight Epidemiology, Forecast, & Market Entry Strategies | Disease Landscape Insights
Published:
2023-10-02
(Crawled : 09:00)
- prnewswire.com
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-24.07%
|
O:
-0.45%
H:
0.39%
C:
-1.17%
disease
market
Alnylam Reports Updated Positive Interim Phase 1 Results for ALN-APP, in Development for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
Published:
2023-07-17
(Crawled : 09:00)
- biospace.com/
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-12.98%
|
O:
0.02%
H:
0.0%
C:
0.0%
REGN
|
$901.27
0.8%
0.78%
470K
|
Health Technology
|
24.44%
|
O:
0.05%
H:
1.33%
C:
0.38%
ALNY
|
$145.23
-1.02%
-1.03%
500K
|
Health Technology
|
-25.56%
|
O:
5.53%
H:
5.23%
C:
-2.49%
disease
alzheimer’s
positive
results
Stargardt Disease Therapeutics Market: Special and Wide … – Digital Journal
Published:
2023-06-23
(Crawled : 09:00)
- spacfeed.com
CLOV
|
$0.6233
-0.27%
-0.27%
6.2M
|
|
-29.16%
|
O:
-0.26%
H:
8.91%
C:
0.74%
disease
therapeutics
Gilead to Present Latest Liver Disease Research at the European Association for the Study of the Liver (EASL) Congress 2023
Published:
2023-06-14
(Crawled : 09:00)
- biospace.com/
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-14.2%
|
O:
-0.52%
H:
0.46%
C:
-0.12%
liver
disease
association
research
study
Positive Results From Pivotal Trials of exa-cel for Transfusion-Dependent Beta Thalassemia and Severe Sickle Cell Disease Presented at the 2023 Annual European Hematology Association (EHA) Congress
Published:
2023-06-09
(Crawled : 09:00)
- biospace.com/
VRTX
|
$393.1
-0.27%
-0.27%
880K
|
Health Technology
|
18.52%
|
O:
0.28%
H:
0.44%
C:
0.18%
CRSP
M
|
$55.56
-4.14%
-4.32%
1.4M
|
Health Technology
|
-7.4%
|
O:
8.5%
H:
0.52%
C:
-9.82%
disease
association
positive
cell
trials
results
Addex Publishes Dipraglurant Data Showing In Vivo Efficacy on Motor and Non-Motor Symptoms of Parkinson’s Disease
Published:
2023-04-04
(Crawled : 09:00)
- biospace.com/
ADXN
|
$22.8
0.89%
0.88%
16K
|
Health Technology
|
13.72%
|
O:
7.68%
H:
2.8%
C:
-13.72%
disease
parkinson’s
Neurodegenerative Disease Therapeutics Industry Expected to Reach USD 28.15 billion by 2030 - Grand View Research, Inc.
Published:
2023-03-21
(Crawled : 09:00)
- prnewswire.com
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-6.13%
|
O:
0.07%
H:
0.08%
C:
-0.07%
disease
expected
therapeutics
neurodegenerative
Sangamo Therapeutics Announces Updated Preliminary Phase 1/2 Data in Fabry Disease Showing Continued Tolerability and Sustained Elevated α-Gal A Enzyme Activity in Nine Patients
Published:
2022-10-12
(Crawled : 09:00)
- biospace.com/
SGMO
|
$0.513
-5.35%
-5.65%
1.2M
|
Health Technology
|
-88.59%
|
O:
-0.21%
H:
0.63%
C:
0.0%
disease
therapeutics
phase 1
Alzheimer's Disease Therapeutics Market to record USD 3.99 Bn growth -- Driven by the availability, research, and development of novel biomarkers
Published:
2022-09-28
(Crawled : 09:00)
- prnewswire.com
GIKLY
|
$4.6
132.75%
4.5K
|
Manufacturing
|
-6.31%
|
O:
-6.72%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
53.92%
|
O:
1.89%
H:
0.0%
C:
0.0%
VTRS
|
$11.095
-0.22%
-0.23%
6.1M
|
Health Technology
|
31.13%
|
O:
0.94%
H:
2.22%
C:
1.99%
NVS
|
News
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
24.34%
|
O:
1.46%
H:
1.25%
C:
0.77%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
14.69%
|
O:
1.76%
H:
0.76%
C:
0.26%
DNLI
|
$16.81
-3.06%
-3.15%
1.4M
|
Health Technology
|
-36.46%
|
O:
6.45%
H:
16.46%
C:
10.57%
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-1.33%
|
O:
43.06%
H:
0.17%
C:
-2.24%
disease
alzheimer's
therapeutics
biomarkers
growth
market
ENHERTU® Significantly Delayed Disease Progression in DESTINY-Breast02 Phase 3 Trial Versus Physician’s Choice of Treatment in Patients with HER2 Positive Metastatic Breast Cancer
Published:
2022-08-15
(Crawled : 09:00)
- biospace.com/
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
2.44%
|
O:
0.92%
H:
0.22%
C:
-0.65%
enhertu
treatment
disease
trial
positive
cancer
her2-
her2
metastatic breast cancer
Acadia Pharmaceuticals Receives Complete Response Letter from U.S. FDA for Supplemental New Drug Application for Pimavanserin for the Treatment of Hallucinations and Delusions Associated with Alzheimer’s Disease Psychosis
Published:
2022-08-05
(Crawled : 09:00)
- biospace.com/
ACAD
|
News
|
$17.2
0.7%
0.7%
1M
|
Health Technology
|
9.35%
|
O:
-2.62%
H:
11.57%
C:
8.09%
treatment
fda
drug
disease
application
alzheimer’s
response
New release of Philips EchoNavigator helps interventional teams treat structural heart disease with greater ease and efficiency
Published:
2022-05-16
(Crawled : 09:00)
- globenewswire.com
PHG
|
News
|
$20.15
-0.89%
0.0%
790K
|
Health Technology
|
-14.79%
|
O:
2.26%
H:
1.76%
C:
1.35%
disease
heart
Bilirubin Blood Test Market 2022-2026 | Increasing Prevalence of Jaundice and Liver Diseases to Boost Growth | Technavio
Published:
2022-05-09
(Crawled : 09:00)
- prnewswire.com
RYLPF
|
News
|
$20.515
3.85%
7K
|
Health Technology
|
-20.39%
|
O:
-2.42%
H:
0.0%
C:
-2.55%
TMO
|
News
|
$547.25
-1.32%
-0.02%
1.6M
|
Health Technology
|
1.87%
|
O:
-1.05%
H:
0.0%
C:
-3.95%
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-2.88%
|
O:
-2.03%
H:
0.0%
C:
0.0%
blood
liver
test
growth
market
disease
Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate
Published:
2022-04-26
(Crawled : 09:00)
- biospace.com/
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-46.27%
|
O:
3.08%
H:
0.0%
C:
0.0%
valneva
disease
report
vaccine
positive
phase 2
Nirsevimab significantly protected infants against RSV disease in Phase 3 trial
Published:
2022-03-03
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-12.02%
|
O:
-6.92%
H:
1.86%
C:
1.86%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-9.01%
|
O:
0.18%
H:
0.0%
C:
0.0%
trial
disease
phase 3
CORRECTING and REPLACING CANbridge Announces Approval of CAN108 for Rare Liver Disease, Alagille Syndrome, Under the Early and Pilot Implementation Policy in Boao Lecheng International Medical Tourism Pilot Zone
Published:
2022-02-25
(Crawled : 09:00)
- biospace.com/
MIRM
|
$23.87
-0.58%
-0.59%
330K
|
Health Technology
|
2.52%
|
O:
0.38%
H:
0.0%
C:
0.0%
can108
rare
liver
approval
disease
liver disease
one
ism
syndros
Relief Announces That Collaboration Partner, Acer Therapeutics, was Issued U.S. Patent 11,202,767 Covering ACER-001 Methods of Use for Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease
Published:
2022-02-01
(Crawled : 09:00)
- biospace.com/
RLFTF
|
$1.35
11.45%
3.5K
|
n/a
|
1700.0%
|
O:
-5.33%
H:
5.63%
C:
3.52%
acer-001
urea
urine
treatment
order
ces
patent
therapeutics
disease
collaboration
← Previous
1
2
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.